Basit öğe kaydını göster

dc.contributor.authorDurna, Zehra
dc.contributor.authorCan, Gülbeyaz
dc.contributor.authorAydiner, Adnan
dc.date.accessioned2021-03-03T13:36:32Z
dc.date.available2021-03-03T13:36:32Z
dc.date.issued2004
dc.identifier.citationCan G., Durna Z., Aydiner A., "Assessment of fatigue in and care needs of Turkish women with breast cancer", CANCER NURSING, cilt.27, sa.2, ss.153-161, 2004
dc.identifier.issn0162-220X
dc.identifier.othervv_1032021
dc.identifier.otherav_34f61c77-c396-40bf-8315-8d092f8cb0ae
dc.identifier.urihttp://hdl.handle.net/20.500.12627/39813
dc.identifier.urihttps://doi.org/10.1097/00002820-200403000-00009
dc.description.abstractUsing Piper's Integrated Fatigue Model, this research project was planned to determine the level of fatigue experienced by Turkish women with breast cancer undergoing adjuvant chemotherapy, to discover the factors affecting fatigue, and to provide a reference by means of which an effective nursing care for such patients could be planned. In assessing the level of fatigue and factors affecting it, a patient information form, the Piper Fatigue Scale, and the Rotterdam Symptom Checklist were used. The reliability tests performed afterwards showed that the scales are appropriate tools for use in Turkish women with breast cancer. Before treatment, psychological symptoms' distress was higher than physical symptoms' distress. However, following treatment, the latter was found to be closer to the former. When pretreatment and posttreatment physical and psychological symptoms were compared, it was noticed that fatigue, nausea, anorexia, vomiting, constipation, depression, and loss of hope for the future were among the symptoms observed to increase the most in the posttreatment period. Different from the other studies, we determined that all of the patients experienced fatigue 7 to 10 days after the chemotherapy cycle and the sensory/affective fatigue scores were high. Breast cancer patients undergoing chemotherapy experienced a moderate level of fatigue, which was influenced by level of income, stage of disease, and symptoms related to chemotherapy, showing compliance with similar studies. Following up patients individually and keeping the treatment-related symptoms under control were noticed to help prevent fatigue.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectHemşirelik
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectHEMŞİRELİK
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleAssessment of fatigue in and care needs of Turkish women with breast cancer
dc.typeMakale
dc.relation.journalCANCER NURSING
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume27
dc.identifier.issue2
dc.identifier.startpage153
dc.identifier.endpage161
dc.contributor.firstauthorID67339


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster